Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

A roundup of the latest drug approvals, including from the pharmaceutical majors, featuring news from Johnson & Johnson, AstraZeneca, and Mylan. Editor's Note: This article was updated on a continuous basis for news announced from...

Takeda Pharmaceutical Company has formed a pact and multi-program option agreement with Wave Life Sciences, a Cambridge, Massachusetts-headquartered biopharmaceutical company, to develop antisense oligonucleotides for genetically defined...

Hikma Pharmaceuticals, an Amman, Jordan-based pharmaceutical company, has appointed Sigurdur Olafsson, a former executive at Teva Pharmaceutical Industries, as chief executive officer (CEO). Olafsson will also join Hikma’s Board of Directors as an...

Astellas has agreed to acquire Universal Cells, a Seattle, Washington-based biopharmaceutical company. Astellas will gain Universal Cells' proprietary Universal Donor Cell technology to create cell-therapy products that do not require human...

Novartis and the Bill & Melinda Gates Foundation have partnered to advance development of Novartis' drug candidate, KDU731, for treating cryptosporidiosis, a parasitic disease. KDU731 is a cryptosporidium lipid kinase phosphatidylinositol-4-OH...

Celgene has completed the first phase a new immunotherapy manufacturing center for chimeric antigen receptor (CAR-T) therapies at its Summit West campus in New Jersey. Celgene says the 135,000-square-foot facility was completed months ahead of the...